PUBLISHER: Grand View Research | PRODUCT CODE: 1609633
PUBLISHER: Grand View Research | PRODUCT CODE: 1609633
The global tele-epilepsy market size is expected to reach USD 1,161.5 million by 2030, registering a CAGR of 15.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. aided by the rising adult population suffering from epilepsy, and increased investments in the healthcare telemedicine ecosystem by governments and private players globally.
The COVID-19 pandemic had a positive impact on the tele-epilepsy industry. The outbreak severely impacted the healthcare system and the economy, which created a special barrier for individuals seeking medical care, including epilepsy care. In addition, telehealth initiatives have demonstrated a high level of patient and physician satisfaction and quality during COVID-19. It has been seen that providing complex epilepsy care, including to patients with severity in epilepsy, could be solved, and can produce results that are comparable to those of in-person consultations.
Governments worldwide are initiating programs to uplift the market for tele-epilepsy. For instance, several government entities are embracing telehealth by implementing new regulations and reimbursement standards. In March 2020, The Federal Communications Commission in the US developed initiatives to aid healthcare organizations in implementing telemedicine technology.